- Home
- DCTH vs MLAB Comparison
DCTH vs MLAB Comparison
Compare DCTH & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- MLAB
- Stock Information
- Founded
- DCTH 1988
- MLAB 1982
- Country
- DCTH United States
- MLAB United States
- Employees
- DCTH N/A
- MLAB N/A
- Industry
- DCTH Medical/Dental Instruments
- MLAB Industrial Machinery/Components
- Sector
- DCTH Health Care
- MLAB Industrials
- Exchange
- DCTH Nasdaq
- MLAB Nasdaq
- Market Cap
- DCTH 388.3M
- MLAB 341.1M
- IPO Year
- DCTH N/A
- MLAB N/A
- Fundamental
- Price
- DCTH $8.62
- MLAB $74.93
- Analyst Decision
- DCTH Strong Buy
- MLAB Hold
- Analyst Count
- DCTH 5
- MLAB 1
- Target Price
- DCTH $22.60
- MLAB $67.00
- AVG Volume (30 Days)
- DCTH 1.3M
- MLAB 86.8K
- Earning Date
- DCTH 11-04-2025
- MLAB 11-06-2025
- Dividend Yield
- DCTH N/A
- MLAB 0.86%
- EPS Growth
- DCTH N/A
- MLAB N/A
- EPS
- DCTH 0.03
- MLAB N/A
- Revenue
- DCTH $79,603,000.00
- MLAB $242,351,000.00
- Revenue This Year
- DCTH $135.11
- MLAB $5.38
- Revenue Next Year
- DCTH $36.30
- MLAB $5.25
- P/E Ratio
- DCTH $250.39
- MLAB N/A
- Revenue Growth
- DCTH 251.54
- MLAB 8.33
- 52 Week Low
- DCTH $8.39
- MLAB $55.45
- 52 Week High
- DCTH $18.23
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- DCTH 30.11
- MLAB 49.95
- Support Level
- DCTH $9.15
- MLAB $71.34
- Resistance Level
- DCTH $10.03
- MLAB $75.80
- Average True Range (ATR)
- DCTH 0.67
- MLAB 3.45
- MACD
- DCTH -0.21
- MLAB -0.51
- Stochastic Oscillator
- DCTH 5.71
- MLAB 33.93
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.